ArticleOncoimmunology2022

Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma.

Liwei Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.